Safety and Feasibility of Intranasal Insulin in Patients With Spinal Cord Injury

Abroad (travel likely)RecruitingPHASE1

Conditions

Spinal Cord Injury

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

HealthPartners Neuroscience Center, Saint Paul, Minnesota, United States
Contact: Study coordinator (Meghan E O'Brien, MPH) · Meghan.E.Obrien@HealthPartners.com · 651-495-6363
Contact: Study coordinator (Bethany K Crouse, PhD) · Bethany.K.Crouse@HealthPartners.com
Contact: Principal Investigator (Leah R Hanson, PhD)

Study leads

Leah R Hanson, PhD
Principal Investigator
HealthPartners Institute
Kimberly Byrnes, PhD
Principal Investigator
Uniformed Services University of the Health Sciences

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Testosterone and Neural Function

Spinal Cord Injury

Abroad (travel likely)RecruitingEARLY_PHASE1

The Bronx, United States

Safety and Early Efficacy of iPSC-Derived Motor Neuron Progenitor Cells (XS228) in Subacute Spinal Cord Injury: A Phase I Trial

Spinal Cord Injury · Safety · Clinical Trials

Abroad (travel likely)RecruitingPHASE1

Guangzhou, China

Innovative Brain-Computer Interface for People With Spinal Cord Injury

Spinal Cord Injury · Tetraplegia C1-C4 · Quadriplegia

Abroad (travel likely)Recruiting

Utrecht, Netherlands

Deep Brain Stimulation in Patients With Incomplete Spinal Cord Injury for Improvement of Gait

Spinal Cord Injury

Abroad (travel likely)Recruiting

Zurich, Switzerland